METHOD FOR EYE TISSUE HYPOXIC DAMAGE SIMULATION WITH APOPTOSIS ACTIVATION Russian patent published in 2017 - IPC G09B23/28 

Abstract RU 2614937 C1

FIELD: medicine.

SUBSTANCE: to simulate the hypoxic damage of eye and retina surface tissues, which leads to apoptosis activation, the experimental animal is exposed to the physical factor. Histological eye tissue samples are obtained and cells being in the apoptosis state are identified therein. The animal is placed into a sealed 0.10-0.15 m3 chamber, where nitrogen gas is delivered at a rate of 2.0-2.4 liter/min, until seizures begin in the experimental animal.

EFFECT: possibility of selective activation of apoptotic processes simultaneously in the eye and retina tissues to assess hypoxia among the factors that cause dry eye syndrome and retinopathy.

6 dwg

Similar patents RU2614937C1

Title Year Author Number
AGENT FOR PREVENTING PROGRESSION OF APOPTOTIC AND ARRESTING NECROTIC ALTERATIONS IN BODY TISSUE 2005
  • Sukojan Galina Viktorovna
  • Kharebava Tengiz Givievich
RU2311180C2
WAY TO CREATE TRANSIENT RETINAL ISCHEMIA 2015
  • Neroev Vladimir Vladimirovich
  • Kiseleva Tatjana Nikolaevna
  • Chudin Anton Vjacheslavovich
  • Beznos Olga Valerevna
  • Khoroshilova Inna Petrovna
  • Shchipanova Aleksandra Ivanovna
  • Slepova Olga Semenovna
  • Balatskaja Natalja Vladimirovna
RU2577242C1
METHOD OF SIMULATING TRANSIENT RETINAL ISCHEMIA IN RATS 2015
  • Kiseleva Tatjana Nikolaevna
  • Chudin Anton Vjacheslavovich
  • Khoroshilova Inna Petrovna
  • Shchipanova Aleksandra Ivanovna
  • Slepova Olga Semenovna
  • Balatskaja Natalja Vladimirovna
RU2577449C1
METHOD FOR DRY EYE SYNDROME TREATMENT IN PATIENTS WITH DIABETES MELLITUS 2020
  • Ryabtseva Alla Alekseevna
  • Ali-Zade Gyunel Khaganovna
  • Akberova Sevindzh Ismail Kyzy
RU2749984C1
APPLICATION OF (2-IMIDAZOLIN-2-YLAMINO) QUINOXALINES IN DEMENTIA AND PARKINSON'S DISEASE TREATMENT 2003
  • Tatton Vil'Jam G.
  • Viler Larri A.
  • Dzhil Dehniehl V.
  • Donello Dzhon E.
RU2332218C2
TREATMENT OF EYE DISEASES SUCH AS MACULAR DEGENERATION, GLAUCOMA AND DIABETIC RETINOPATHY WITH MEDICATIONS THAT ELIMINATE AGING CELLS 2018
  • Hopkins, Jill
  • Tsuruda, Pam
  • Chapman, Claude
  • Sweigard, Harry
  • Poon, Yan
  • Marquess, Daniel
  • David, Nathaniel
  • Dananberg, Jamie
  • Laberge, Remi-Martin
RU2815482C2
METHOD OF INCREMENT IN RETINA CAPACITY WITH VARIOUS PATHOLOGIES 2008
  • Revishchin Aleksandr Vladimirovich
  • Zueva Marina Vladimirovna
  • Tsapenko Irina Vladimirovna
  • Chentsova Ekaterina Valer'Janovna
  • Saburina Irina Nikolaevna
  • Kuprashvili Iosif Tamazovich
RU2364382C1
CDP-CHOLINE - PROPHYLACTIC AGENT FOR TREATMENT OF CEREBRAL ISCHEMIA AND METHOD FOR TREATMENT WITH ITS USING 2001
  • Kastello Khosep M.
  • Losano Rafaehl'
  • Ortis Khose A.
  • Raga Manuehl'
  • Ramentol' Khorkhe
  • Sekades Khulio Kh.
  • Ferrer Isidro Kh.
  • Foget Rafaehl'
RU2255741C2
PHARMACEUTICAL PREPARATION CONTAINING SUPERNATANT OF BLOOD MONONUCLEAR CELL CULTURE 2009
  • Ankersmit Khendrik Jan
RU2533253C2
AGENT WITH ANTIAPOPTOTIC ACTIVITY 2018
  • Kampe-Nemm Elena Arturovna
  • Kolobov Aleksandr Aleksandrovich
  • Rogovskaya Nadezhda Yurevna
  • Babakov Vladimir Nikolaevich
RU2685428C1

RU 2 614 937 C1

Authors

Ryabtseva Alla Alekseevna

Markitantova Yuliya Vladimirovna

Ali-Zade Gyunel Khagani Kyzy

Akberova Sevindzh Ismail Kyzy

Babaev Khanaga Fizuli Ogly

Dates

2017-03-30Published

2016-04-12Filed